Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen S Atkins

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
BMC Genomics|March 30, 2007
ATP-binding cassette systems in Burkholderia pseudomallei and Burkholderia malleiDavid N Harland, Elie Dassa, Richard W Titball, et al.
Microbial Pathogenesis|July 3, 2007
Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases CBrendan N Neeson, Graeme C Clark, Helen S Atkins, et al.
BMC Microbiology|June 2, 2018
High-throughput analysis of Yersinia pseudotuberculosis gene essentiality in optimised in vitro conditions, and implications for the speciation of Yersinia pestisSamuel J Willcocks, Richard A Stabler, Helen S Atkins, et al.
Peptides|February 1, 2012
Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin IIMarc A Fox, Joanne E Thwaite, David O Ulaeto, et al.
Research in Microbiology|December 15, 2015
Burkholderia pseudomallei kynB plays a role in AQ production, biofilm formation, bacterial swarming and persistenceAaron Butt, Nigel Halliday, Paul Williams, et al.
Clinical and Vaccine Immunology : CVI|March 27, 2009
Development and characterization of mouse models of infection with aerosolized Brucella melitensis and Brucella suisSophie J Smither, Stuart D Perkins, Carwyn Davies, et al.
Plos One|March 25, 2021
Drug screening to identify compounds to act as co-therapies for the treatment of Burkholderia speciesSam Barker, Sarah V Harding, David Gray, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2016
A Bioluminescent Francisella tularensis SCHU S4 Strain Enables Noninvasive Tracking of Bacterial Dissemination and the Evaluation of Antibiotics in an Inhalational Mouse Model of TularemiaCharlotte A Hall, Helen C Flick-Smith, Sarah V Harding, et al.
Vaccine|September 4, 2007
Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracisGraeme J M Cowan, Helen S Atkins, Linda K Johnson, et al.
Vaccine|April 16, 2009
Small protective fragments of the Yersinia pestis V antigenClaire Vernazza, Bry Lingard, Helen C Flick-Smith, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
BMC Genomics|March 30, 2007
ATP-binding cassette systems in Burkholderia pseudomallei and Burkholderia malleiDavid N Harland, Elie Dassa, Richard W Titball, et al.
Microbial Pathogenesis|July 3, 2007
Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases CBrendan N Neeson, Graeme C Clark, Helen S Atkins, et al.
BMC Microbiology|June 2, 2018
High-throughput analysis of Yersinia pseudotuberculosis gene essentiality in optimised in vitro conditions, and implications for the speciation of Yersinia pestisSamuel J Willcocks, Richard A Stabler, Helen S Atkins, et al.
Peptides|February 1, 2012
Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin IIMarc A Fox, Joanne E Thwaite, David O Ulaeto, et al.
Research in Microbiology|December 15, 2015
Burkholderia pseudomallei kynB plays a role in AQ production, biofilm formation, bacterial swarming and persistenceAaron Butt, Nigel Halliday, Paul Williams, et al.
Clinical and Vaccine Immunology : CVI|March 27, 2009
Development and characterization of mouse models of infection with aerosolized Brucella melitensis and Brucella suisSophie J Smither, Stuart D Perkins, Carwyn Davies, et al.
Plos One|March 25, 2021
Drug screening to identify compounds to act as co-therapies for the treatment of Burkholderia speciesSam Barker, Sarah V Harding, David Gray, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2016
A Bioluminescent Francisella tularensis SCHU S4 Strain Enables Noninvasive Tracking of Bacterial Dissemination and the Evaluation of Antibiotics in an Inhalational Mouse Model of TularemiaCharlotte A Hall, Helen C Flick-Smith, Sarah V Harding, et al.
Vaccine|September 4, 2007
Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracisGraeme J M Cowan, Helen S Atkins, Linda K Johnson, et al.
Vaccine|April 16, 2009
Small protective fragments of the Yersinia pestis V antigenClaire Vernazza, Bry Lingard, Helen C Flick-Smith, et al.
Pageof 7